PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Dr. Karen Smith, MD, PhD, MBA, ...

PHILADELPHIA − The Eagles made two trades with their original third-round pick, getting out of the round entirely. In the process, the Eagles got extra picks in both the 2025 and 2026 drafts.

Board Member Dr. Karen Smith to serve as Interim Chief Medical OfficerPHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context ...

London's FTSE 100 index, which has gained 4.8% since the beginning of the year, was 0.8% higher at 1:00 p.m. in the U.K. on Friday — putting it on track for its longest ever run of daily gains.

The Super Bowl champion Philadelphia Eagles can improve on the league's best roster in the 2025 NFL draft. With Brandon Graham's retirement and Milton Williams leaving via free agency, the Eagles ...

President Donald Trump arrives to welcome the Super Bowl champion Philadelphia Eagles NFL football team to the South Lawn of ...

Century Therapeutics Inc. company and executive profile by Barron's. View the latest IPSC company infomation and executive bios.

European stocks closed higher on Tuesday, with results out from HSBC, Lufthansa, Volvo Cars, Adidas, BP, AstraZeneca, ...

AstraZeneca, Tempus and Pathos AI have signed a multi-year agreement to develop a large-scale multimodal deep learning model designed to accelerate cancer drug discovery. The companies say the ...

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ultimately be used to develop new cancer drugs. Tempus will use its “vast ...

Astrazeneca's chief executive, Pascal Soriot, has warned that Europe is jeopardising its "ability to protect the health of its own people at risk" by not investing sufficiently. He further stated that ...